Ideas For Now-

SHORT REPORT!---MSTR

A) Citi downgrades MicroStrategy to Sell on 'overextended' rally, bitcoin focus 07:40 MSTR Citi analyst Tyler Radke downgraded MicroStrategy to Sell from Neutral with a price target of $250, up from $200. The recent rally in the shares is "overextended," says Radke, who sees "incremental risks to the story" following an announced $400M convertible note to fund even more bitcoin purchases. Recent insider selling has been "significant and broad based," and suggests shares may be overvalued, Radke tells investors in a research note. Much of the management team may not be as optimistic on bitcoin or MicroStrategy's fundamentals as CEO Michael Saylor, he adds. Radke is concerned that the company could be losing focus on execution with CEO Saylor's "disproportionate focus" on bitcoin.
 
YES!

Hologic price target raised to $100 from $85 at Argus

The Play Of The Day--- verra mobility???????

Verra Mobility price target raised to $15 from $13 at BTIG 11/24 VRRM BTIG analyst Mark Palmer raised the firm's price target on Verra Mobility to $15 from $13 and keeps a Buy rating on the shares. Palmer said that while Verra's cashless tolling payment business in the U.S. continues to be "severely" challenged by depressed activity in the rental car space, he believes the stock is likely to build on its recent momentum as an effective vaccine for COVID-19 comes closer to reality. The analyst added that the potential for Verra's tolling revenues makes it the most compelling reopening story within his coverage universe.

Is this e-z pass?????

Yesterday-- Call spread buyer in Verra Mobility adding to position 13:40 VRRM Call spread buyer in Verra Mobility adding to position. Shares of the road transportation services company up 27c, or 2.1%, this afternoon near $13.26 with unusually heavy call volume after a buyer paid 93c to $1 for a total of 2k July 15/20 call spreads. Looks to add to 4k already open from late November when shares were lower and a buyer paid 77.5c for 2k and 90c for 2k. Verra Mobility traded near $17 pre-covid before finding support near $6 in April.

VAN?????
 
Yuliia is great and very pretty but she is a high bar jumper and they come with their problems.
Her gate or walk in the street is exactly like her run to the bar as you will see in this vid-- it's not a pretty way to walk. Strolling down the Avenue with her I noticed several bystanders getting injured.
 
SHORT REPORT-!

B) GrowGeneration files to sell $125M of common stock 16:41 GRWG Oppenheimer and Stifel are acting as joint book running managers for the offering. Show Related Items >>
 
Group 1 Automotive VP Delongchamps sells almost $380K in shares 13:34 GPI Group 1 Automotive VP Peter Delongchamps sold 3,000 shares at $126.50 on December 4 for a total transaction amount of $379,500.
 
At least once before I asked for a huge winner in a short amount of time... is that too much to ask? After the hundreds of winners that are in this thread.. well at least 50 I would say looking at my trading activity I am out of control!!! and up $600K.

Now I know you are going to say: why should we help someone who is up that much? Well consider my wife's spending, my grotto removal project, my inclination to buy art at auctions and my extremely expensive smoke habit.

So I am asking again from all these Elite Traders... Give Me A Huge Winner that I can say That's it!!! I'm done for a month or two...

It seems I am always the one giving.

NGM Three letters. No Promises but I would buy this stock. We own it in The Ideas For Now Portfolio and have done quite well thank you. We have this as our 2021 Bio ,along with Bicycle. So these are not this years stories... however.... On December 9, 2020 at 12:00 pm ET. NGM is having a sort of virtual analyst day...

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced it will host a virtual R&D Day on December 9, 2020 at 12:00 pm ET.

The R&D Day will highlight NGM’s productive, 100+ researcher-led discovery engine and feature NGM’s pipeline of drug candidates in liver and metabolic diseases (aldafermin and MK-3655), retinal disease (NGM621) and cancer (NGM120 and NGM707).

Normally I would say eh, this is not exactly a conference... any Co can hold a day but NGM did slide this into the press release...

NGM also plans to unveil an additional oncology candidate at the event.

Who Knows... It could be for a big target population, it could get analysts to chirp about the stk and their reports would be published on the 10th THE VERY DAY WE ARE RECOMMENDING GETTING OUT OF THE MARKET.

So Unconventional Wisdom BUY NGM First... let me watch this penny stock and make sure it can work and then on the 10th I may reveal all!!!!!~stoney
 
$39 but I thought it was $33.......:)

Van-- You mentioned VUZI and got me thinking about the Samrt Glasses Again. What do you think of VUZI?

I have to go out for an hour but lets VUZI talk later.. also I cannot wait for all the " ideas " to come in.... people think this is easy until you ask them outright...

I did fudge my numbers a bit... The Hedge Fund has a bunch of ideas in my account and I have legacy names from my Grandmother with cost basis in the 1930's real pain in the ass... so some of my $600K will be from that... probably $200K-- the rest is me. Still a great year!~si
 
You must log in or register to reply here.
Back
Top